secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0000917520-23-000079
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences appoints Jeff Graves to board; adopts exec severance program
--------------------------------------------------------------------------------

- Jeffrey Alan Graves, CEO of 3D Systems, appointed to board effective Dec 12, 2023, filling an existing vacancy.
- Graves is independent; will receive pro-rated annual retainer and director equity grants under standard policy.
- Change in control severance program adopted effective Jan 1, 2024, covering CFO Lea Knight and other named executives.
- Program provides lump sum of 1.5x (2x for CFO) base salary plus target bonus, COBRA, and outplacement upon qualifying termination.
- Program expires Dec 31, 2024, but automatically extends for two years upon a change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000079/0000917520-23-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000079/iart-20231212.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer